Centaurus Financial Inc. reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 49.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 575 shares of the company’s stock after selling 564 shares during the period. Centaurus Financial Inc.’s holdings in HCA Healthcare were worth $119,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently modified their holdings of the stock. Sanders Capital LLC raised its position in HCA Healthcare by 3.4% in the second quarter. Sanders Capital LLC now owns 8,062,121 shares of the company’s stock valued at $1,782,684,000 after purchasing an additional 266,566 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of HCA Healthcare by 111.3% during the first quarter. JPMorgan Chase & Co. now owns 4,777,608 shares of the company’s stock worth $899,815,000 after buying an additional 2,516,289 shares during the period. Bank of New York Mellon Corp lifted its holdings in HCA Healthcare by 11.9% in the first quarter. Bank of New York Mellon Corp now owns 2,968,099 shares of the company’s stock valued at $559,011,000 after buying an additional 314,801 shares during the period. Lyrical Asset Management LP raised its position in shares of HCA Healthcare by 0.3% in the 1st quarter. Lyrical Asset Management LP now owns 2,110,986 shares of the company’s stock worth $397,583,000 after acquiring an additional 6,446 shares in the last quarter. Finally, Nuveen Asset Management LLC boosted its position in shares of HCA Healthcare by 2.2% during the 1st quarter. Nuveen Asset Management LLC now owns 2,096,700 shares of the company’s stock valued at $394,892,000 after purchasing an additional 44,691 shares in the last quarter. Institutional investors and hedge funds own 68.57% of the company’s stock.
Several research firms have recently weighed in on HCA. Barclays reiterated a “neutral” rating on shares of HCA Healthcare in a research note on Friday, August 27th. Cowen started coverage on HCA Healthcare in a research report on Thursday, September 9th. They issued an “outperform” rating and a $293.00 target price for the company. Zacks Investment Research cut HCA Healthcare from a “buy” rating to a “hold” rating and set a $218.00 price objective for the company. in a research note on Tuesday, June 15th. Truist boosted their target price on shares of HCA Healthcare from $260.00 to $290.00 and gave the stock a “buy” rating in a research report on Wednesday, July 21st. Finally, Credit Suisse Group boosted their price objective on HCA Healthcare from $222.00 to $267.00 and gave the stock an “outperform” rating in a report on Wednesday, July 21st. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $241.57.
HCA Healthcare stock opened at $258.74 on Friday. The company has a debt-to-equity ratio of 18.06, a current ratio of 1.45 and a quick ratio of 1.21. HCA Healthcare, Inc. has a one year low of $114.38 and a one year high of $263.92. The firm has a market capitalization of $82.83 billion, a P/E ratio of 17.75, a PEG ratio of 1.38 and a beta of 1.65. The business has a fifty day moving average price of $246.50 and a 200-day moving average price of $216.37.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Monday, July 19th. The company reported $4.37 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.16 by $1.21. The firm had revenue of $14.44 billion for the quarter, compared to analysts’ expectations of $13.61 billion. HCA Healthcare had a return on equity of 234.29% and a net margin of 8.87%. The company’s revenue was up 30.4% on a year-over-year basis. During the same period in the prior year, the business posted $3.23 earnings per share. Sell-side analysts expect that HCA Healthcare, Inc. will post 16.78 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 30th. Stockholders of record on Thursday, September 16th will be issued a $0.48 dividend. The ex-dividend date of this dividend is Wednesday, September 15th. This represents a $1.92 annualized dividend and a dividend yield of 0.74%. HCA Healthcare’s payout ratio is currently 16.54%.
HCA Healthcare Profile
HCA Healthcare, Inc is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.
Recommended Story: Example of operating income, EBIT and EBITDA
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.